Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002408:Catheters, Indwelling; D002939:Ciprofloxacin; D003556:Cystitis / Q000188:drug therapy; D004756:Enterobacteriaceae Infections / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications*; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*; D011704:Pyelonephritis / Q000188:drug therapy; D011804:Quinolines / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D000890:Anti-Infective Agents; D011804:Quinolines; D002939:Ciprofloxacin